Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Watch out for Board appointments

If they appoint someone to the board who has ties to big tech companies that mean they are going to be bought out. If management are scumbags they will sell cheap so they get big bonuses in the more

I need another coffee...

Posted the wrong article... There is an article this morning in La Presse's electronic pad version, about yesterday's news.  Since I can't copy it on this board, I searched it in more

Top Gainers

And the second highest trading volume this year. GLTA Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes, as of more

La Presse - Richard Dufour

Opsens a annonc lundi qu’elle venait d’obtenir l’approbation de Sant Canada pour lancer la premire tude clinique chez l’homme auprs d’une vingtaine de patients pour son dispositif mdical utilis lors more

Investors conference

The FDA approval today will definitely attract lots of attention in Boston.   rate and reply

My theory did not work!

I putted a 7000 shares bid on the block at 3.14$ and got eaten up  instantly. Dont try this at home!  rate and reply


Someone in the market is putting huge ask right now 25,000 shares are on the block in order to scare small investors. I suspect its the same people putting a small bid 2 cents below the ask waiting more

RE:RE:The best tool

This FDA approval is the first step in the eventual buyout of our little company . It's only a matter of time . GLTA   rate and reply

RE:The best tool

Congrats to the Opsens team, great news.  rate and reply

The best tool

I dont think that cardiologist are going to settle for anything less than the best tool in the market and this weekend its going to be common knowledge what the best tool is. Im still buying this is more

Weak Market

I guess I should be appreciative of today's market as it gave me an opportunity to add more at $2.96 when I didn't expect it to fall below $3.00. As is obvious, the Canadian market is more

Another milestone to bring Opaens to a new level...

The global TAVR market is currently estimated at over 200,000 procedures and is expected to reach 400,000 in 2027. The OptoWire has been used in the diagnosis and treatment of over 150,000 patients more

RE:What we need now

Right now the speculators need to jump ship after that we can only hope for big investors to come in. Nasdaq listing would help but most importantly announcing sales is what is going to drive more

RE:RE:Just two days notice

Same to you Nadia !  rate and reply

USA Listing

They should apply for a proper US listing, that would open up to a large new investor base.  rate and reply

RE:Just two days notice

Your feeling was right ivebeenthere, congratulations to you and to all longs!  rate and reply

What we need now

What id like to see now is a declined take over offer at 4$ or 5$. Then let the offers roll in. Enjoy the day everyone   rate and reply


September 15, 2022 Opsens Inc. FDA approval of SavvyWire received slightly ahead of expected timelines TSX: OPS | CAD 2.79 | Outperform | Speculative Risk | more

Cannot be a better timing...and a wishing thinking i dream!

" commented Louis Laflamme, President and Chief Executive Officer of OpSens. "SavvyWire uniquely provides a 3-in-1 solution for stable aortic valve delivery and positioning, more